White paper

From the bench to the clinic: The rapidly changing expectations of process development

Biopharmaceutical companies rely on their process development teams to move innovations from early discovery into the clinic and manufacturing. In recent years, we have seen an increase in the volume, speed, and complexity of work faced by process development organizations. How should these teams respond? We had the opportunity to sit down with three process development professionals at our annual Benchtalk industry conference in Boston to discuss exactly this.

In this white paper we cover:
  • The top business priorities for modern therapeutic development

  • The toughest challenges faced in reaching these goals

  • Successful approaches towards staying at the forefront

Companies using Benchling

View white paper

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image